SBFMWSunshine Biopharma Inc. Warrant
0.0499USDMkt Cap: —P/E: —5d ago
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)35.35M $
Gross Profit12.26M $
Net Income (TTM)-5.98M $
Revenue/Share49.67 USD
Last Price0.0499 USD
Fiscal Year End—
MR Quarter—
Employees50
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.00
EPS (TTM)-2.21
EPS (Forward)—
52W Range
—
52W High0.0499 USD
52W Low0.0499 USD
Profitability
Gross Margin33.76%
Oper. Margin-17.41%
EBITDA Margin-13.72%
Profit Margin-16.46%
ROE-25.94%
ROA-19.87%
Growth
Revenue Growth-1.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.33M $
CapEx (TTM)836.31K $
FCF Margin-5.69%
FCF Yield—
Net Debt-13.35M $
Net Debt/EBITDA2.75
Balance Sheet
Debt/Equity0.04
Current Ratio5.46
Quick Ratio3.21
Book Value/Sh43.83 USD
Cash/Share3.618 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float3.75M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta1.31
S&P 52W Chg21.00%
Avg Vol (30d)2
Avg Vol (10d)—
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—